| Accession Number: | 0000899243-21-048599 |
| Date: | 2021-12-15 |
| Issuer: | TALARIS THERAPEUTICS, INC. (TALS) |
| Original Submission Date: |
NADER FRANCOIS
C/O TALARIS THERAPEUTICS, INC.
570 S. PRESTON STREET
LOUISVILLE, KY 40202
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2021-12-15 | G | 59,520 | d | $0.00 | 336,167 | indirect | f1 |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | these shares are held in a trust for the benefit of the reporting person's spouse and child. the reporting person's spouse and child are trustees of the trust. the reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of section 16 or for any other purpose. |
